Crossref
Advanced Ovarian Cancer: Assessing the Role of Cytoreductive Surgery and HIPEC
International Journal of Pharmaceutical Quality Assurance · 11.07.2026 · 16 (12)
DOI: 10.25258/ijpqa.16.12.139 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 11.07.2026. Verfasst von Chiranjit Mukherjee und 2 weiteren Autor:innen.
Abstract (Originalsprache)
.
Zitieren
APA
Mukherjee, C., Ghosh, S., & Singh, S. (2026). Advanced Ovarian Cancer: Assessing the Role of Cytoreductive Surgery and HIPEC. International Journal of Pharmaceutical Quality Assurance, 16(12). https://doi.org/10.25258/ijpqa.16.12.139
Vancouver
Mukherjee C, Ghosh S, Singh S. Advanced Ovarian Cancer: Assessing the Role of Cytoreductive Surgery and HIPEC. International Journal of Pharmaceutical Quality Assurance. 2026;16(12). doi:10.25258/ijpqa.16.12.139
BibTeX
@article{Mukherjee2026,
author = {Mukherjee, Chiranjit and Ghosh, Somdeep and Singh, Suman},
title = {Advanced Ovarian Cancer: Assessing the Role of Cytoreductive Surgery and HIPEC},
journal = {International Journal of Pharmaceutical Quality Assurance},
year = {2026},
volume = {16},
number = {12},
doi = {10.25258/ijpqa.16.12.139}
}
EUVIMED